All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression
Damián E. Berardi(Universidad de Buenos Aires), Laura B. Todaro(National University of General San Martín)
Cited by 16